M. P. Glauser

Discipline

Psychologie (3) Sociologie (1) Philosophie (1) Sciences de l'information et de la communication (1)

Type de document

Articles (22) Recensions (3)

Co-auteur

Date

Source

Mot-clé

Human beings (11) Patients (9) Patients (9) Immunoglobulins (8) Escherichia coli (8) Treatment (7) Rats (6) Animals (6) Pyelonephritis (5) Immunization (5) Use (5) Infections (5) mutant (4) anticorps (4) infection (4) maladie (4) méthode (4) adulte (4) Protection (4) Shock (4) Serum (4) Septic shock (4) Infection (4) Gram-negative bacteria (4) Escherichia (4) Older people (4) Protection (4) adulte (4) nucleus (4) maladie (4)

Documents écrit par M. P. Glauser (22) | parle de M. P. Glauser (0)

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000
O. Marchetti et al.
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy
A. Cometta et al.
An epidemic of food-borne listeriosis in western Switzerland: description of 57 cases involving adults
C. J. Bula et al.
Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS
P. Gallay et al.
Pathogenesis and potential strategies for prevention and treatment of septic shock: an update
M. P. Glauser et al.
Bactericidal/Permeability-Increasing Protein Inhibits Induction of Macrophage Nitric Oxide Production by Lipopolysaccharide
S. B. Corradin et al. (1994)
Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides
D. Heumann et al.
Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5
J. D. Baumgartner et al.
Use of Immunoglobulins in Prevention and Treatment of Infection in Critically III Patients: Review and Critique
G. Zanetti et al. (1991)
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group
T. Calandra et al.
Role of complement-derived and bacterial formylpeptide chemotactic factors in the in vivo migration of neutrophils in experimental Escherichia coli pyelonephritis in rats
P. R. Meylan et al.
Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study
J. P. Chave et al.
Interpretation of Data Regarding the Protection Afforded by Serum, IgG, or IgM Antibodies after Immunization with the Rough Mutant R595 of Salmonella minnesota
J. D. Baumgartner et al. (1989)
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial
T. Calandra et al.
Failure of dexamethasone to prevent polymorphonuclear leukocyte infiltration during experimental acute exudative pyelonephritis and to reduce subsequent chronic scarring
P. R. Meylan et al.
Single-dose rifampin prophylaxis for experimental endocarditis induced by high bacterial inocula of viridans streptococci
R. Malinverni et al.
Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5
J. D. Baumgartner et al.
Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient
J. D. Baumgartner et al.
Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia
J. Bille et al.
Chronic Candida Arthritis in Leukemic Patients
M. P. Glauser et al. (1982)
Prevention of Pyelonephritis Due to Escherichia coli in Rats with Gentamicin Stored in Kidney Tissue
M. P. Glauser et al. (1979)
Synergism of Ampicillin and Gentamicin against Obstructive Pyelonephritis Due to Escherichia coli in Rats
M. P. Glauser et al. (1979)